Kliniska studier för Lupus i Pennsylvania
14 studier för Lupus söker deltagare vid platser i Pennsylvania.
Städer i Pennsylvania
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50365, Pittsburgh
RekryterarFas 3
Ålder 16 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Temple University, Philadelphia
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research, Duncansville
RekryterarFas 2
Ålder 18 till 74 · Alla kön · Uppdaterad 1 okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University Of Pittsburgh, Pittsburgh
RekryterarFas 3
Ålder 12 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Philadelphia
RekryterarFas 3
Ålder 5 till 17 · Alla kön · Uppdaterad 30 sep. 2026 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Clinical Research Philadelphia, Philadelphia
RekryterarFas 3
Ålder 18 till 75 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1/2
Ålder 10 till 29 · Alla kön · Uppdaterad 24 sep. 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Fox Chase Cancer Center- Temple BMT, Philadelphia
RekryterarFas 2
Ålder 16 till 70 · Alla kön · Uppdaterad 17 sep. 2026 · NCT07328581A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0075, Philadelphia
- Local Institution - 0052, Philadelphia
RekryterarObservationsstudie
Ålder 16 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 1/2
Ålder 18 till 65 · Alla kön · Uppdaterad 26 aug. 2026 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Penn State MS Hershey Medical Center, Hershey
RekryterarFas 3
Ålder 55 och äldre · Alla kön · Uppdaterad 20 aug. 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
RekryterarFas 1
Ålder 12 till 70 · Alla kön · Uppdaterad 22 maj 2026 · NCT06308978Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Children's Hospital of Philadelphia, Philadelphia
RekryterarFas 2
Ålder 8 till 25 · Alla kön · Uppdaterad 14 okt. 2025 · NCT05029336Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.